Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.

Lemoine, Maud; Shimakawa, Yusuke; Njie, Ramou; Taal, Makie; Ndow, Gibril; Chemin, Isabelle; Ghosh, Sumantra; Njai, Harr F; Jeng, Adam; Sow, Amina; +19 more... Toure-Kane, Coumba; Mboup, Souleymane; Suso, Penda; Tamba, Saydiba; Jatta, Abdullah; Sarr, Louise; Kambi, Aboubacar; Stanger, William; Nayagam, Shevanthi; Howell, Jessica; Mpabanzi, Liliane; Nyan, Ousman; Corrah, Tumani; Whittle, Hilton; Taylor-Robinson, Simon D; D'Alessandro, Umberto; Mendy, Maimuna; Thursz, Mark R; PROLIFICA investigators; (2016) Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study. The Lancet Global health, 4 (8). e559-e567. ISSN 2214-109X DOI: https://doi.org/10.1016/S2214-109X(16)30130-9

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2214-109X(16)30130-9

Abstract

Share

Download

Filename: Acceptability and feasibility_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar